Research: Grant History

The table below charts the grants that have been provided to FSHD researchers since the inception of this organization. We have been able to provide such funding only because of you. Each and every grant request is carefully scrutinized by our Advisory Board to ensure that we get the biggest return on our investment. So far we have been able to provide just over $1.3 million for research, with future commitments of another $500,000. Of course to meet those commitments, we need to continue our Annual Auction, which provides most all of the funding.

2005 $50,000 FRG1 Research (year 1)
October 1, 2005
Brian Kennedy & Steve Hauschka
2006 $50,000 FSHD Related Defects in Human Myogenesis (year 1)
June 14, 2006
Dan Miller & Stephen Tapscott
$50,000 FRG1 Research (year 2)
October 1, 2006
Brian Kennedy & Steve Hauschka
$2,500 FSH Research Seattle Conference
December 1, 2006
2007 $14,845 DUX4 Expression
June 28, 2007
Alexandria Belayeu
$50,000 Development of an RNAi-based therapy for FSHD (year 1)
July 9, 2007
Joel Chamberlain
$50,000 FRG1 Research (year 3) (final paper)
November 4, 2007
Brian Kennedy & Steve Hauschka
$50,000 FSHD Related Defects in Human Myogenesis (year 2)
November 4, 2007
Dan Miller & Stephen Tapscott
2008 $28,000 FSHD Research
May 29, 2008
Sara Winokur
$50,000 Development of an RNAi-based therapy for FSHD (year 2) (progress)
July 29, 2008
Joel Chamberlain
$15,690 MR Evaluation of Skeletal Muscles
August 15 2008 (results)
Seth Friedman, Dennis Shaw, et. al.
$50,000 D4Z4/DUX4 Induced Pathologies in Mice (year 1) (summary)
August 15, 2008
Michael Kyba
$50,000 FSHD Research (year 1) (summary) (progress)
August 15, 2008
Stephen Tapscott
2009 $56,000 Joint Project Funding
April 1, 2009
Stephen Tapscott
$19,000 Joint Project Funding
April 1, 2009
Dan Miller
$50,000 D4Z4/DUX4 Induced Pathologies in Mice (year 2) (summary)
August 14, 2009
Michael Kyba
$50,000 FSHD Research (year 2) (progress)
August 14, 2009
Stephen Tapscott
$25,000 Joint Project Funding - transition funding
September 15, 2009
Dan Miller
2010 $50,000 Joint Project Funding - transition funding (summary)
January 23, 2010
Dan Miller & Stephen Tapscott
$50,000 RNA Interference as an investigative & therapeutic tool for FSHD (year 1)
April 6, 2010
Joel Chamberlain
$50,000 Using model organisms to identify new therapies and understand the pathogenesis of Facioscapulohumeral Muscular Dystrophy (Year 1) (progress)
November 1, 2010
Barbara Page (mentoring researcher — Stephen Tapscott)
2011 $50,000 RNA Interference as an investigative & therapeutic tool for FSHD (year 2) (update)
February 14, 2011
Joel Chamberlain
$50,000 Mechanism of Wnt Signaling in Facioscapulohumeral Muscular Dystrophy (Year 1) (update)
April 15, 2011
Gregory Block (mentoring researcher — Daniel Miller)
$60,000 Platform development and candidate drug screening for FSHD (Year 1) (summary)
August 18, 2011
Daniel Miller
$70,000 Postnatal Modeling of FSHD in Wild-Type Mice (Year 1)
September 1, 2011
Joel Chamberlain
$50,000 Using model organisms to identify new therapies and understand the pathogenesis of Facioscapulohumeral Muscular Dystrophy (Year 2)
November 1, 2011
Barbara Page (mentoring researcher — Stephen Tapscott)
$12,500 Development of anti-DUX4 therapeutics for FSHD (Year 1) (summary)
October 31, 2011
Michael Kyba
$36,000 Longitudinal Progression of Edema and Fatty Replacement of Lower Extremity Muscles in FSHD (summary)
November 18, 2011
Seth Friedman, Dennis Shaw, et. al.
$125,000 Modulators of Epigenetic Disease (Year 1) (summary)
November 25, 2011
Stephen Tapscott
Our Donors

Please take a moment to view our generous donors.

Connect With Us